Company Filing History:
1 out of 1,743 
1 out of 5,081 
1 out of 132 
Years Active: 2018
Title: Michael Dussiot: Innovator in Cancer Treatment
Introduction
Michael Dussiot is a notable inventor based in Paris, France. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on addressing drug-resistant cancers and improving patient outcomes.
Latest Patents
Dussiot holds a patent for a composition that combines a DNA methylation inhibitor and a vitamin D receptor agonist. This invention is aimed at treating drug-resistant cancer and preventing tumor relapse. The patent outlines the use of these two components either simultaneously or sequentially to enhance the sensitivity of cancer patients to chemotherapeutic drugs.
Career Highlights
Throughout his career, Michael Dussiot has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Dussiot has collaborated with notable colleagues, including Ivan Cruz-Moura and Olivier Hermine. These partnerships have further enriched his research and development efforts in the field of cancer treatment.
Conclusion
Michael Dussiot is a pioneering inventor whose work in cancer treatment has the potential to change lives. His innovative approach to combining DNA methylation inhibitors with vitamin D receptor agonists represents a significant advancement in the fight against drug-resistant cancers.